Trial Profile
Clinical Trials Insight: 700035662
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jul 2008
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Merrion Pharmaceuticals
- 24 Jul 2008 New trial record.